logo
Robert E. Ginna Jr., whose article bolstered UFO claims, dies at 99

Robert E. Ginna Jr., whose article bolstered UFO claims, dies at 99

Boston Globe20-03-2025
Advertisement
To the general public, though, he was perhaps best known for an article he wrote with H.B. Darrach Jr. for the April 7, 1952, issue of Life magazine. The cover featured an alluring photograph of Marilyn Monroe under the headline 'There Is a Case for Interplanetary Saucers.'
Get Starting Point
A guide through the most important stories of the morning, delivered Monday through Friday.
Enter Email
Sign Up
To Mr. Ginna's eternal dismay, the article made him a target for UFO buffs and kooks. Headlined 'Have We Visitors From Space?' it examined 10 reports of unidentified flying object sightings, followed by an unequivocal assessment from German rocket expert Walther Riedel: 'I am completely convinced that they have an out-of-world basis.'
While reports of UFOs in the late 1940s were often trivialized, Phillip J. Hutchison and Herbert J. Strentz wrote in American Journalism in 2019: "By the early 1950s, however, more substantial human-interest features embraced the idea that U.F.O. reports might correspond to extraterrestrial Earth visitors. A widely cited April 7, 1952, Life magazine feature titled 'Have We Visitors From Space?' represents one of the most influential examples of the latter trend."
Captain Edward J. Ruppelt, who led the Air Force's internal UFO investigation, Project Blue Book, wrote in 'The Report on Unidentified Flying Objects' in 1956 that 'the Life article undoubtedly threw a harder punch at the American public than any other UFO article ever written.'
Other reporters had visited the Air Technical Intelligence Center (now the National Air and Space Intelligence Center), in Dayton, Ohio, he wrote, but 'for some reason the name LIFE, the prospects of a feature story, and the feeling that this Bob Ginna was going to ask questions caused sweat to flow at ATIC.'
Advertisement
"Life didn't say that the U.F.O.s were from outer space; it just said maybe," he added. "But to back up this 'maybe,' it had quotes from some famous people," including Riedel. (In 2024, a congressionally mandated Pentagon report concluded that there was no evidence that any UFO sightings represented alien visits.)
Throughout his career, Mr. Ginna 'carved his own path,' Jeremy Gerard, a critic, biographer and former reporter for The New York Times, said in an email.
He "quoted Yeats and O'Casey" and "valued his correspondences with many of the great writers of his time," Gerard noted, and he wasn't afraid to go his own way, "leaving People when its direction didn't please him, devoting himself to teaching when the literary world was changing at warp speed, worshipping at the altar of the written word."
Robert Emmett Ginna Jr. was born on Dec. 3, 1925, in Brooklyn. He was named for Irish patriot Robert Emmet, as was his father, an electrical engineer who became the chair of Rochester Gas and Electric. His mother, Margaret (McCall) Ginna, was the daughter of Irish immigrants.
In addition to his son, Peter, an editor and writer, he is survived by his daughter, Mary Frances Williams Ginna; a sister, Margretta Michie; two grandchildren; and a great-grandson. His wife, Margaret (Williams) Ginna, died in 2004. His first marriage, to Patricia Ellis, ended in divorce; they had no children. After his wife's death, he was the companion of journalist Gail Sheehy, who died in 2020.
Advertisement
After graduating from the Aquinas Institute of Rochester, he enrolled at Harvard College, but dropped out to join the Navy when he was 17 and served in the Pacific during World War II. He graduated from the University of Rochester in 1948.
Mr. Ginna envisioned a career in medical research and was already working in a laboratory when, traveling in France, he was struck by what he described as an epiphany as he gazed at one of the rose windows at the cathedral in Chartres. He returned home and changed direction, earning a master's degree in art history at Harvard and working briefly as a curator of painting and sculpture at the Newark Museum of Art.
Later in his 20s, Mr. Ginna was a freelance writer for the Gannett group of newspapers before joining Life in 1950. His interview of Irish dramatist Sean O'Casey for NBC would inspire him to produce a film called 'Young Cassidy' (1965), based on O'Casey's memoir. (Sean Connery was supposed to star, but opted to play James Bond instead.)
Mr. Ginna also produced 'Before Winter Comes' (1969), starring David Niven, Anna Karina, John Hurt, and Israeli actor Topol, and 'Brotherly Love' (1970), starring Peter O'Toole and Susannah York.
'As a producer, Ginna may have had limitations,' Salter wrote of their Hollywood misadventures in his memoir, 'Burning the Days' (1997). 'He was scrupulously honest. He was a classicist — his interests were cultural, his knowledge large — and unequivocal in his statements and beliefs.'
After working at People, where he was a founding editor in 1974, he went on to serve as editor-in-chief of Little, Brown from 1977 to 1980, his son said. There, he published 'Coma,' the first medical thriller by Cook. He then briefly returned to Time Inc., which was trying to revive Life. Beginning in 1987, he taught writing and film at Harvard University. He took his final publishing job at 80, starting an academic press at New England College, in Henniker, N.H.
Advertisement
When Mr. Ginna was in his early 70s, he traversed the length of Ireland, lugging a 38-pound rucksack, a journey he recounted in 'The Irish Way: A Walk Through Ireland's Past and Present' (2003). In 2016, at 90, he retired from teaching but continued to write. He left an uncompleted memoir titled 'Epiphanies.'
This article originally appeared in
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Medieval skeletons reveal the lasting damage of childhood malnutrition
Medieval skeletons reveal the lasting damage of childhood malnutrition

Yahoo

time17 hours ago

  • Yahoo

Medieval skeletons reveal the lasting damage of childhood malnutrition

Beneath churchyards in London and Lincolnshire lie the chemical echoes of famine, infection and survival preserved in the teeth of those who lived through some of the most catastrophic periods in English history. In a new study, my colleagues and I examined over 270 medieval skeletons to investigate how early-life malnutrition affected long-term health and life expectancy. We focused on people who lived through the devastating period surrounding the Black Death (1348-1350), which included years of famine during the little ice age and the great bovine pestilence (an epidemic that killed two-thirds of cattle in England and Wales). We found that the biological scars of childhood deprivation during this time left lasting marks on the body. These findings suggest that early nutritional stress, whether in the 14th century or today, can have consequences that endure well beyond childhood. Children's teeth act like tiny time capsules. The hard layer inside each tooth, called dentine, sits beneath the enamel and forms while we're growing up. Once formed, it stays unchanged for life, creating a permanent record of what we ate and experienced. As our teeth develop, they absorb different chemical versions (isotopes) of carbon and nitrogen from our food, and these get locked into the tooth structure. This means scientists can read the story of someone's childhood diet by analysing their teeth. A method of measuring the chemical changes in sequential slices of the teeth is a recent advance used to identify dietary changes in past populations with greater accuracy. When children are starving, their bodies break down their fat stores and muscle to continue growing. This gives a different signature in the newly formed dentine than the isotopes from food. These signatures make centuries-old famines visible today, showing exactly how childhood trauma affected health in medieval times. We identified a distinctive pattern that had been seen before in victims of the great Irish famine. Normally, when people eat a typical diet, the levels of carbon and nitrogen in their teeth move in the same direction. For example, both might rise or fall together if someone eats more plants or animals. This is called 'covariance' because the two markers vary together. But during starvation, nitrogen levels in the teeth rise while carbon levels stay the same or drop. This opposite movement – called 'opposing covariance' – is like a red flag in the teeth that shows when a child was starving. These patterns helped us pinpoint the ages at which people experienced malnutrition. Lifelong legacy Children who survived this period reached adulthood during the plague years, and the effect on their growth was recorded in the chemical signals in their teeth. People with famine markers in their dentine had different mortality rates than those who lacked these markers. Children who are nutritionally deprived have poorer outcomes in later life: studies of modern children have suggested that children of low birth weight or who suffer stresses during the first 1,000 days of life have long-term effects on their health. For example, babies born small, a possible sign of nutritional stress, seem to be more prone to illnesses such as heart disease and diabetes in adulthood than the population at large. These characteristics can also be passed to future offspring through changes in how genes are switched on or off, known as 'epigenetic effects' – which can endure for three generations. In medieval England, early nutritional deprivation may have been beneficial during catastrophic times by producing adults of short stature and the capacity to store fat, but these people were much more likely to die after the age of 30 than their peers with healthy childhood dentine patterns. The patterns for childhood starvation increased in the decades leading up to the Black Death and declined after 1350. This suggests the pandemic may have indirectly improved living conditions by reducing population pressure and increasing access to food. The medieval teeth tell us something urgent about today. Right now, millions of children worldwide are experiencing the same nutritional crises that scarred those long-dead English villagers – whether from wars in Gaza and Ukraine or poverty in countless countries. Their bodies are writing the same chemical stories of survival into their growing bones and teeth, creating biological problems that will emerge decades later as heart disease, diabetes and early death. Our latest findings aren't just historical curiosities; they're an urgent warning that the children we fail to nourish today will carry those failures in their bodies for life and pass them on to their own children. The message from the medieval graves couldn't be clearer: feed the children now or pay the price for generations. Get your news from actual experts, straight to your inbox. Sign up to our daily newsletter to receive all The Conversation UK's latest coverage of news and research, from politics and business to the arts and sciences. This article is republished from The Conversation under a Creative Commons license. Read the original article. Julia Beaumont receives funding from Arts and Humanities research council, British Academy/Leverhulme.

Pandemic darlings Moderna, BioNTech are now on two different paths
Pandemic darlings Moderna, BioNTech are now on two different paths

CNBC

timea day ago

  • CNBC

Pandemic darlings Moderna, BioNTech are now on two different paths

The Covid-19 pandemic turned Moderna and BioNTech into household names almost overnight. Now the two companies are on different paths. Both Moderna and BioNTech helped pioneer mRNA, or messenger RNA, technology. Moderna staked its entire identity around mRNA, while BioNTech saw it as one piece of a broader portfolio focused on immunology and oncology. The pandemic gave both companies a chance to prove mRNA's promise of using the body's own immune system to protect against viruses or treat diseases. Covid vaccines have generated roughly $45 billion in sales for each company, earning them each about $20 billion since their rollout in late 2020. But despite parallel booms after the pandemic, the vaccine makers have since taken their businesses in different directions — and Wall Street has noticed. The two companies have spent their Covid vaccine windfall differently: Moderna doubled down on its mRNA pipeline, while BioNTech used the money to do deals and diversify, including into one of the hottest emerging areas of cancer drugs. Today, Moderna has about $8.4 billion in cash; the German-based BioNTech has €15.9 billion (or $18.2 billion). The divergence of the two companies is even more stark in their stock performance. Over the past year, Moderna shares have slid about 72%; BioNTech shares have gained nearly 29%. "Just their name was made based off the pandemic and the vaccines that they very quickly brought to people around the world to help get us through that period of time," said Evercore ISI analyst Cory Kasimov. "But the approach they're taking now and the outlook for these two companies is distinctly different at this point." Investors will get a fresh look at both companies' performance as they post quarterly results in the coming days. Moderna is set to report Friday morning, followed by BioNTech on Monday morning. Moderna used its Covid cash to build out its mRNA portfolio, particularly vaccines. It invested in shots for flu, RSV and lesser-known viruses like cytomegalovirus and norovirus. "From our perspective, the pandemic really showed that the science of what we're doing worked, and the natural sort of response to that was to continue down that path and do more," said Moderna President Stephen Hoge. Funding such a large pipeline wasn't cheap. The company has started slashing expenses as sales of its Covid vaccine slide and its RSV vaccine struggles to find a foothold. But the clock is running, said Leerink analyst Mani Foroohar. "We're moving into a time where being a vaccine company is going to be more expensive, tedious and onerous," Foroohar said, citing changes at the Food and Drug Administration under the leadership of Health and Human Services Secretary Robert F. Kennedy Jr., who has expressed skepticism about vaccines. Foroohar in 2022 pointed out what he saw as a Shakespearean tragic flaw in Moderna's business model. That shortcoming, in his view, is that Moderna scaled its pipeline assuming mRNA technology would be the tool for all problems instead of a solution for some problems. Hoge said Moderna's "really good at making mRNA medicines" and decided to focus on doing that. "The reality is that we think over the last 10 years, that focus has actually made us successful, and in the pandemic, it certainly had a big impact and obviously was something that sets us up for the more diverse pipeline we have right now," Hoge said. "So we recognize that we may be going through some cycles, but we're pretty confident in the long-term trajectory we're on, and we're looking forward over the years ahead to showing with all these additional medicines what we're really capable of." Meanwhile, BioNTech decided to use the proceeds from its Covid vaccine to diversify. Out of the limelight as partner Pfizer took the lead on selling the companies' shot, BioNTech expanded into promising new cancer technologies. Most importantly, it acquired a bispecific antibody targeting the proteins PD-L1 and VEG-F. That technology promises to build on – and possibly best – the success that Merck has found with Keytruda, a cancer drug with nearly $30 billion in sales last year alone. That thesis still needs to be proven in large, global clinical trials, but BioNTech is already seeing that deal pay off. Bristol Myers Squibb in June announced it would pay up to $11 billion to partner with BioNTech to codevelop the experimental drug, which BioNTech acquired for a fraction of that. BioNTech in 2023 initially paid Biotheus $55 million up front to license the drug outside China before acquiring the company outright earlier this year for up to $1 billion. "[BioNTech] found an asset, they developed it, and then they got a pharma partner, it's like a dream," said BMO analyst Evan David Seigerman. "So they're really strategic in that, and I think they're adding a lot of diversification, which makes the story a lot less risky if you're just focused on mRNA, vaccines and Covid, and that's super risky, in my view." At the same time, hopes are high that BioNTech's bispecific antibody drug will work, meaning any disappointment ahead could hurt the stock. Investors are watching forthcoming Phase 3 trial results from Summit Therapeutics, which is testing a similar drug for lung cancer. Those data could help — or hurt — BioNTech's stock while it awaits data from its own studies, which could take until 2028. For Moderna, investors want to see if sales of its Covid and RSV vaccines can rebound. The company is also seeking FDA approval for an mRNA flu shot. But at this point, the most intense focus is on Moderna's Phase 3 trial for a personalized cancer treatment for melanoma, said RBC Capital Markets analyst Luca Issi. Moderna may be able to share the first interim data as soon as next year, Hoge said, though the company can't promise an exact date since it's an event-driven study. That means enough people in the trial need to relapse before Moderna can analyze whether its treatment kept cancer from returning longer. If the treatment succeeds, it could launch in 2027 or 2028, Hoge said. That leaves Moderna largely dependent on its vaccines until then. An ongoing patent dispute over Moderna's Covid-19 shot could also eat into the company's cash, analysts say, adding they expect the legal proceedings to play out next year. Time will tell whether the divergent strategies win over Wall Street long term.

Video shows sea lions diving off cliff after massive earthquake strikes Russia's far east
Video shows sea lions diving off cliff after massive earthquake strikes Russia's far east

USA Today

time2 days ago

  • USA Today

Video shows sea lions diving off cliff after massive earthquake strikes Russia's far east

A powerful earthquake that struck Russia's Kamchatka Peninsula on July 30 prompted a group of sea lions to dive into nearby waters in search of safety, footage of the ordeal shows. The video taken by a tourist on a nature day trip shows at least 30 sea lions jumping off cliffs and into the waves for safety as an 8.8-magnitude earthquake struck the island of Antsiferov. The earthquake also prompted tsunami alerts along America's West Coast, from Alaska to Hawaii, with no immediate damage reported. Meanwhile, authorities in Ecuador's Galapagos Islands have ordered a precautionary evacuation for residents living in vulnerable areas along the Pacific coast, according to Reuters. More on sea lions on the island The island affected by the earthquake is home to Steller sea lions, the largest members of the family Otariidae, which includes "eared seals," according to the National Oceanic and Atmospheric Administration Fisheries. The species was named after German surgeon and naturalist Georg Wilhelm Steller, who described it in 1742, according to NOAA Fisheries. The seals can be found mainly along the North Pacific Ocean rim from northern Hokkaido, Japan, to the Kuril Islands and Sea of Okhotsk. They can also be found in the Aleutian Islands and Bering Sea, the southern coast of Alaska and south to central California. Adult males tend to be much larger than females, the agency said. Adult males can be up to 11 feet long and can weigh up to 2,500 pounds, while adult females are 7.5 to 9.5 feet long and weigh up to 800 pounds. They primarily feed at night and consume over 100 species of fish, including mackerel, walleye pollock, salmon, Pacific cod, flounder and others. They can forage both nearshore and offshore, and can travel long distances within a single season. Disturbances and how they impact sea lions The creatures need 'undisturbed land habitat to rest, molt, socialize, mate, give birth, and nurse small pups during the breeding season,' NOAA Fisheries said. The agency also said Steller sea lions have been disturbed in the past by powerboats, kayaks, paddleboards and other watercraft, as well as approaching aircraft.. 'Disturbance to Steller sea lions on terrestrial haulout sites can lead to individuals fleeing toward the water, causing mass stampedes during which pups and juveniles may be injured or killed when crushed by adults,' the agency said. 'Disturbance can also cause sea lions to flee from the tops of steep rocks or cliff faces, also causing injury or death.' Saleen Martin is a reporter on USA TODAY's NOW team. She is from Norfolk, Virginia – the 757. Email her at sdmartin@

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store